381 related articles for article (PubMed ID: 34571171)
81. Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site.
Hu X; Li L; Zhang Q; Wang Q; Feng Z; Xu Y; Xia Y; Yu L
Bioorg Chem; 2020 Apr; 97():103695. PubMed ID: 32120073
[TBL] [Abstract][Full Text] [Related]
82. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
83. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors.
Ma Y; Wang T; Cheng L; Ma X; Li R; Zhang M; Chen J; Zhao P
Bioorg Med Chem Lett; 2024 Aug; 108():129816. PubMed ID: 38806101
[TBL] [Abstract][Full Text] [Related]
84. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Fallah M; Ghassemi-Barghi N; Ghasemian M; Emami S
Eur J Med Chem; 2020 Jan; 185():111784. PubMed ID: 31669850
[TBL] [Abstract][Full Text] [Related]
85. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors.
Wang YT; Shi TQ; Zhu HL; Liu CH
Bioorg Med Chem; 2019 Feb; 27(3):502-515. PubMed ID: 30606674
[TBL] [Abstract][Full Text] [Related]
86. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937
[TBL] [Abstract][Full Text] [Related]
87. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
88. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization.
Zhang R; Mo H; Ma YY; Zhao DG; Zhang K; Zhang T; Chen X; Zheng X
Bioorg Med Chem Lett; 2021 May; 40():127968. PubMed ID: 33753264
[TBL] [Abstract][Full Text] [Related]
89. Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1
Wang Q; Arnst KE; Wang Y; Kumar G; Ma D; White SW; Miller DD; Li W; Li W
J Med Chem; 2019 Jul; 62(14):6734-6750. PubMed ID: 31251599
[TBL] [Abstract][Full Text] [Related]
90. New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies.
Abdul Hussein SA; Razzak Mahmood AA; Tahtamouni LH; Balakit AA; Yaseen YS; Al-Hasani RA
Chem Biodivers; 2023 Apr; 20(4):e202201206. PubMed ID: 36890635
[TBL] [Abstract][Full Text] [Related]
91. Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1
Wang C; Li Y; Liu Z; Wang Z; Liu Z; Man S; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):549-560. PubMed ID: 33522315
[TBL] [Abstract][Full Text] [Related]
92. Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors.
Tan Y; Hu H; Zhu W; Wang T; Gao T; Wang H; Chen J; Xu J; Xu S; Zhu H
Eur J Med Chem; 2023 Dec; 262():115881. PubMed ID: 37883897
[TBL] [Abstract][Full Text] [Related]
93. A novel series of benzothiazepine derivatives as tubulin polymerization inhibitors with anti-tumor potency.
Wang B; Wang LR; Liu LL; Wang W; Man RJ; Zheng DJ; Deng YS; Yang YS; Xu C; Zhu HL
Bioorg Chem; 2021 Mar; 108():104585. PubMed ID: 33508676
[TBL] [Abstract][Full Text] [Related]
94. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
95. Design, Synthesis and Evaluation of 2,4-Diaminoquinazoline Derivatives as Potential Tubulin Polymerization Inhibitors.
Herrera-Vázquez FS; Matadamas-Martínez F; Aguayo-Ortiz R; Dominguez L; Ramírez-Apan T; Yépez-Mulia L; Hernández-Luis F
ChemMedChem; 2020 Oct; 15(19):1802-1812. PubMed ID: 32686342
[TBL] [Abstract][Full Text] [Related]
96. Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors.
Narva S; Chitti S; Amaroju S; Bhattacharjee D; Rao BB; Jain N; Alvala M; Sekhar KVGC
Bioorg Med Chem Lett; 2017 Aug; 27(16):3794-3801. PubMed ID: 28684120
[TBL] [Abstract][Full Text] [Related]
97. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
[TBL] [Abstract][Full Text] [Related]
98. Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity.
Mourad AAE; Mourad MAE; Jones PG
Drug Des Devel Ther; 2020; 14():3111-3130. PubMed ID: 32848361
[TBL] [Abstract][Full Text] [Related]
99. Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Hashemi SM; Mirzaei H; Fallah M; Emami S
Bioorg Chem; 2019 Dec; 93():103300. PubMed ID: 31586708
[TBL] [Abstract][Full Text] [Related]
100. Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors.
Zhang S; Mo M; Lv M; Xia W; Liu K; Yu G; Yu J; Xu G; Zeng X; Cheng S; Xu B; Luo H; Meng X
Future Med Chem; 2023 Nov; 15(21):1967-1986. PubMed ID: 37937524
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
